Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biovista has entered into a research collaboration agreement with Novartis to focus on identifying new indications for a number of undisclosed Novartis compounds using Biovista's Clinical Outcome Search Space (COSS) technology.
Subscribe to our email newsletter
Biovista is a biotechnology company that profiles novel uses and side effects for existing drugs using their mechanism of action.
Biovista president Aris Persidis said they look forward to work with Novartis to enhance their drug discovery efforts.
"Our unique COSS technology offers significant advantages in terms of speed, comprehensiveness and depth of clinical outcome exploration, which we expect will help patients in need of novel solutions," Persidis said.